Team:Montgomery Cougars NJUSA/Extras/References

From 2014hs.igem.org

(Difference between revisions)
(References)
Line 9: Line 9:
Oberemok, Steve S., and Alan R. Shalita. "Acne vulgaris, I: pathogenesis and diagnosis." CUTIS-NEW YORK- 70.2 (2002): 101-105.
Oberemok, Steve S., and Alan R. Shalita. "Acne vulgaris, I: pathogenesis and diagnosis." CUTIS-NEW YORK- 70.2 (2002): 101-105.
 +
 +
Ozer Arican, Ergul Belge Kurutas, Sezai Sasmaz. Mediators Inflamm. 2005 December 14; 2005(6): 380–384. doi: 10.1155/MI.2005.380
{{Montgomery_Cougars_NJUSA/Layout_End:Two_Column}}
{{Montgomery_Cougars_NJUSA/Layout_End:Two_Column}}
{{Montgomery_Cougars_NJUSA/Sidebar}}
{{Montgomery_Cougars_NJUSA/Sidebar}}

Revision as of 12:36, 26 May 2014

References

Bhatia A, Maisonneuve JF, Persing DH. PROPIONIBACTERIUM ACNES AND CHRONIC DISEASES. In: Institute of Medicine (US) Forum on Microbial Threats; Knobler SL, O'Connor S, Lemon SM, et al., editors. The Infectious Etiology of Chronic Diseases: Defining the Relationship, Enhancing the Research, and Mitigating the Effects: Workshop Summary. Washington (DC): National Academies Press (US); 2004.

Higaki, Shuichi. "Lipase Inhibitors for the Treatment of Acne." Journal of Molecular Catalysis B: Enzymatic 22.5-6 (2003): 377-84. Print.

Lee WL, Shalita AR, Sunthralingam K, et al. Neutrophil chemotaxis to Proprionibacterium acnes lipase and its inhibition. Infect Immun. 1982;35:71–78.

Oberemok, Steve S., and Alan R. Shalita. "Acne vulgaris, I: pathogenesis and diagnosis." CUTIS-NEW YORK- 70.2 (2002): 101-105.

Ozer Arican, Ergul Belge Kurutas, Sezai Sasmaz. Mediators Inflamm. 2005 December 14; 2005(6): 380–384. doi: 10.1155/MI.2005.380

Our Project

Extras